Clinical Trials Browser

Interventional × Non Small Cell Lung Cancer NSCLC × Clear all

NCT03164616 2026-03-13

POSEIDON

Phase 3 Active not recruiting

1,186 enrolled 26 charts 1 FDA

Non Small Cell Lung Cancer NSCLC

NCT06680050 2025-12-18

AUSTRAL

Phase 2 Recruiting

Non Small Cell Lung Cancer NSCLC

NCT07188480 2025-09-23

The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients

Phase NA Recruiting

Non Small Cell Lung Cancer NSCLC

NCT07087223 2025-07-25

Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure

Phase 1/2 Recruiting

Non Small Cell Lung Cancer NSCLC